Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Abstract Background The role of the gut microbiota in Crohn’s disease (CD) is established and fecal microbiota transplantation (FMT) is an attractive therapeutic strategy. No randomized controlled clinical trial results are available. We performed a randomized, single-blind, sham-controlled pilot tr...

Full description

Bibliographic Details
Main Authors: Harry Sokol, Cecilia Landman, Philippe Seksik, Laurence Berard, Mélissa Montil, Isabelle Nion-Larmurier, Anne Bourrier, Guillaume Le Gall, Valérie Lalande, Alexis De Rougemont, Julien Kirchgesner, Anne Daguenel, Marine Cachanado, Alexandra Rousseau, Élodie Drouet, Michelle Rosenzwajg, Hervé Hagege, Xavier Dray, David Klatzman, Philippe Marteau, Saint-Antoine IBD Network, Laurent Beaugerie, Tabassome Simon
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Microbiome
Subjects:
Fecal microbiota transplantation
Crohn’s disease
Randomized controlled trial
Online Access:https://doi.org/10.1186/s40168-020-0792-5

Internet

https://doi.org/10.1186/s40168-020-0792-5

Similar Items